California’s Department of Cannabis Control opened a regular rulemaking October 30 to preserve a process that lets eligible cannabis retailers separate a combined medicinal and adult-use license. The proposal, DCC-2026-04-R, is a step toward permanent regulations, not an announcement that every operator has changed its license or received federal approval.
The department says 95 licensed businesses have already obtained separate medicinal and adult-use licenses under emergency rules adopted June 4. That figure describes California licensing changes. It does not establish that those businesses have registered successfully with the Drug Enforcement Administration, a separate process that remains central to the department’s rationale.
What California is trying to preserve
In its initial statement of reasons, DCC describes operators trying to maintain adult-use business while exploring a distinct medicinal operation. The agency says federal registration guidance has been limited, leaving some licensees waiting for more clarity before changing their structure.
The proposed pathway would allow a business with a combined designation to retain an adult-use license and receive a new medicinal license through an expedited state process. A related legal entity could hold the separate license if the applicable conditions are met. Participation is voluntary, and the agency says it cannot quantify how many additional eligible operators will choose it.
That distinction matters for readers following cannabis reform. A new configuration can give a business another option without changing every rule governing the products it sells. The state is addressing the shape of its licensing system; it is not issuing a blanket statement that all commercial cannabis activity has become federally lawful.
Separate licenses still carry shared responsibilities
The proposed text requires related entities at the same premises to share the same individual owners and designated responsible party. Cannabis goods would have to be physically separated by license, with inventory and tracking records identifying which license holds them. Business records would also be maintained separately.
The entities would be jointly and severally liable for obligations, debts and violations under either license. The proposal treats the related licenses as one licensee for compliance and enforcement purposes. In practical terms, organizational separation would come with documentation duties rather than an opportunity to place problems outside the regulator’s reach.
Retailers would also have to comply with local requirements. The text preserves the restriction that goods designated for medical use only may be sold only to medicinal customers. A second license would not turn that label into an ordinary adult-use product or eliminate the need to identify the appropriate customer.
How a modification request would work
The draft rule lists the information required for a modification: the existing combined license, the name for the medicinal license, the submitting designated responsible party, business-formation records, a federal employer identification number and a valid seller’s permit number. The department would review a request within five business days and identify deficiencies in writing if the requirements were not satisfied.
Existing inventory would stay in the adult-use license’s track-and-trace account at the point of separation. That provision gives the change a defined starting position: a retailer cannot simply relabel its entire stock as belonging to the new medicinal operation without following the applicable inventory requirements.
The displayed proposal includes both a provision about paying an applicable annual medicinal-license fee before inventory transfers and a provision saying no fee is due until renewal for a newly issued medicinal license. Operators should ask DCC to explain how those provisions apply together, rather than build a budget around an assumed fee exemption. This is a useful subject for public comment.
Potential benefits are not guaranteed outcomes
The rulemaking notice estimates about 1,600 licensees could be affected and classifies approximately 97 percent as small businesses. Those are agency estimates of the potentially eligible population, not a prediction that every business will apply or that another 1,600 stores will open.
DCC frames greater flexibility for pursuing federal medicinal registration as a potential benefit. Its discussion also acknowledges uncertainty around future participation and the federal process. Operators should distinguish an agency’s policy objective from a completed registration, a confirmed tax treatment or a demonstrated improvement in profitability.
Comments come before final adoption
Written comments must be received by December 14, 2026. The department plans a virtual public hearing December 15 beginning at 10 a.m.; its notice explains how to request access and where the meeting link will be posted. Read the official notice before preparing a submission so the comment addresses this rulemaking.
For now, California is proposing continuity for a licensing option already used under emergency regulations. The substantive questions are whether the process is clear, how separate records work in practice and what guidance operators still need. The number of state license splits is one measure of uptake; federal registration and business outcomes remain different questions.
Illustrative stock office records; not DCC files or records from a cannabis licensee. Photo: Pixabay / Pexels.